DEVELOPING AN ALGORITHM TO IDENTIFY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA IN AN ADMINISTRATIVE CLAIMS DATABASE
Author(s)
Agarwal S1, McManus A1, Querbes W1, Simon A1, Noxon V2, Cole A2, Johnson BH2
1Alnylam Pharmaceuticals, Cambridge, MA, USA, 2Truven Health Analytics, an IBM Company, Cambridge, MA, USA
OBJECTIVES : Acute hepatic porphyrias (AHPs) are rare genetic diseases consisting of acute and chronic manifestations caused by mutations in heme synthesis enzymes. Prior to implementation of ICD-10-CM, identifying AHP patients was limited due to ICD-9-CM having only one non-specific porphyria code. This study developed an algorithm to identify AHP patients in a claims database. METHODS : Truven Health MarketScan Research Databases were used to identify a definitive AHP population using ICD-10-CM E80.21 (acute intermittent [hepatic] porphyria) between 10/1/2015 – 12/31/2015 and possible AHP patients between 1/1/2010 – 09/30/2015. A four-pronged approach to develop an algorithm combined non-specific AHP claims, common symptoms, diagnostic testing, and hemin (only approved treatment) to identify patients prior to 10/1/2015. The algorithm was tested by comparing the 6-month emergency room (ER) visit frequency prior to diagnosis among the definitive AHP population with the non-specific population given the high frequency of ER visits in this population due to acute attacks. RESULTS : CONCLUSIONS : Identifying rare diseases using claims is challenging with non-specific diagnosis codes. This is the first claims-based algorithm to identify AHP patients using ICD-9-CM in combination with symptoms and urinalysis.
Conference/Value in Health Info
2018-05, ISPOR 2018, Baltimore, MD, USA
Value in Health, Vol. 21, S1 (May 2018)
Code
PRM18
Topic
Clinical Outcomes, Real World Data & Information Systems, Study Approaches
Topic Subcategory
Clinical Outcomes Assessment, Reproducibility & Replicability
Disease
Rare and Orphan Diseases